From microtissues to macro solutions – The future of scalable and automated cartilage tissue engineering

The burden of articular cartilage damage on society continues to rise. Suitable treatment is necessary to reduce pain, improve quality of life, and avoid progression into osteoarthritis. Current regenerative cartilage repair strategies remain limited in clinical practice due to high costs, complex logistics, patient burden, and poor reimbursement. To ensure that treatment innovations effectively reach the patient, the focus during development should be on automated and scalable solutions. A promising concept is using cartilage microtissues as building blocks in a modular approach to create larger cartilage constructs. By enabling controlled microtissue assembly and reproducible, scalable manufacturing, this could lead to the efficient production of tissue-engineered cartilage implants. Several automated, scalable steps have been described in literature, ranging from cell isolation and expansion to microtissue formation and harvesting, and finally to macrotissue assembly and maturation. However, integrating all these steps into a single, cost-effective, and automated process remains a conceptual idea. This review focuses on potential routes and key choices that should be considered in the early design process of future ready-to-implant tissue-engineered cartilage implants. Furthermore, the added value of investigating and implementing automatic quality measures and cleaning protocols, as well as the recommended regulatory checks and cost-effectiveness implications, are discussed. The translational potential of this article: Leveraging microtissues for cartilage tissue engineering in a scalable, automated, and GMP-compliant manner could address the growing burden of articular cartilage damage. This review shows the translational potential of this approach by focusing on the early implementation of these concepts in the design process of cartilage tissue-engineered solutions, ensuring compatibility and viability within current healthcare systems.

Authors

Institutions

Publication Details

Journal
Journal of Orthopaedic Translation
Published
2026-06-08
DOI
https://doi.org/10.1016/j.jot.2026.101150
Primary Topic
Osteoarthritis Treatment and Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

From microtissues to macro solutions – The future of scalable and automated cartilage tissue engineering

Sebastien J. P. Callens, A Vasilopoulou, Jasmijn V. Korpershoek, Florencia Abinzano et al.
Journal of Orthopaedic Translation
Osteoarthritis Treatment and Mechanisms
article

From microtissues to macro solutions – The future of scalable and automated cartilage tissue engineering

Sebastien J. P. Callens, A Vasilopoulou, Jasmijn V. Korpershoek, Florencia Abinzano, Ioannis Papantoniou, Daphne M.A. Menssen, J Malda, Aylin Kara Özenler, Daniel J. Kelly, Keita Ito
article en

Abstract

The burden of articular cartilage damage on society continues to rise. Suitable treatment is necessary to reduce pain, improve quality of life, and avoid progression into osteoarthritis. Current regenerative cartilage repair strategies remain limited in clinical practice due to high costs, complex logistics, patient burden, and poor reimbursement. To ensure that treatment innovations effectively reach the patient, the focus during development should be on automated and scalable solutions. A promising concept is using cartilage microtissues as building blocks in a modular approach to create larger cartilage constructs. By enabling controlled microtissue assembly and reproducible, scalable manufacturing, this could lead to the efficient production of tissue-engineered cartilage implants. Several automated, scalable steps have been described in literature, ranging from cell isolation and expansion to microtissue formation and harvesting, and finally to macrotissue assembly and maturation. However, integrating all these steps into a single, cost-effective, and automated process remains a conceptual idea. This review focuses on potential routes and key choices that should be considered in the early design process of future ready-to-implant tissue-engineered cartilage implants. Furthermore, the added value of investigating and implementing automatic quality measures and cleaning protocols, as well as the recommended regulatory checks and cost-effectiveness implications, are discussed. The translational potential of this article: Leveraging microtissues for cartilage tissue engineering in a scalable, automated, and GMP-compliant manner could address the growing burden of articular cartilage damage. This review shows the translational potential of this approach by focusing on the early implementation of these concepts in the design process of cartilage tissue-engineered solutions, ensuring compatibility and viability within current healthcare systems.

Journal of Orthopaedic TranslationVol. 59
Mayo Clinic (US), Utrecht University (NL), Trinity College Dublin (IE), University Medical Center Utrecht (NL), Mayo Clinic in Arizona (US), Eindhoven University of Technology (NL), KU Leuven (BE)
Nederlandse Organisatie voor Wetenschappelijk Onderzoek, European Research Council, HORIZON EUROPE Reforming and enhancing the European Research and Innovation system
Openalex Percentile: Top 6%
Osteoarthritis Treatment and Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.